A Randomized, Study Investigating the Efficacy of Visual Acuity-based Versus Optical Coherence Tomography (OCT) -Based Treat and Extend Regimen Using Aflibercept in Patients With Diabetic Macular Edema
Latest Information Update: 19 Jun 2023
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms AVOCT
- 15 Mar 2021 Status changed from recruiting to discontinued.
- 25 Mar 2020 Planned End Date changed from 1 Dec 2022 to 1 Dec 2024.
- 11 Jan 2018 New trial record